Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach

Indian J Pharmacol. 2020 Jan-Feb;52(1):1-5. doi: 10.4103/ijp.IJP_119_20. Epub 2020 Mar 11.

Authors

Phulen Sarma¹, Manisha Prajapat¹, Pramod Avti², Hardeep Kaur¹, Subodh Kumar¹, Bikash Medhi¹

Affiliations

¹ Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Biophysics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

No abstract available

Publication types

Editorial
Review

MeSH terms

Antiviral Agents / adverse effects
Antiviral Agents / therapeutic use*
Betacoronavirus / drug effects*
Betacoronavirus / pathogenicity
COVID-19
COVID-19 Drug Treatment
Clinical Decision-Making
Coronavirus Infections / diagnosis
Coronavirus Infections / drug therapy*
Coronavirus Infections / epidemiology
Coronavirus Infections / virology
Evidence-Based Medicine
Host Microbial Interactions
Humans
Immunologic Factors / adverse effects
Immunologic Factors / therapeutic use*
Molecular Targeted Therapy
Pandemics
Patient Selection
Pneumonia, Viral / diagnosis
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / virology
SARS-CoV-2
Treatment Outcome

Substances

Antiviral Agents
Immunologic Factors